FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to molecular biology, specifically proteins regulating cell differentiation by Wnt family protein inhibition and may be used in medicine for prevention and treatment of the diseases caused by disturbed Wnt signal path activity. e.g. colon cancer, melanoma, carcinoma.
EFFECT: invention enables blocking a signal path activated by the Wnt8 family factor in the animal cells by the introduction of nogginI or noggin2 protein into tissue containing Wnt8 protein in the amount effective for Wnt8 activity inhibition.
3 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF BLOCKING SINGALLING PATHWAY ACTIVATED BY TGF-beta FACTOR DERRIERE IN ANIMAL CELLS | 2009 |
|
RU2407799C1 |
| METHOD OF BLOCKING SIGNAL PATH ACTIVATED BY TGF-beta FACTOR OF VgI IN ANIMAL CELLS | 2008 |
|
RU2391352C1 |
| NOGGIN2-BASED ACTIVIN ACTIVITY BLOCKING METHOD | 2005 |
|
RU2354662C2 |
| METHOD OF STEM CELLS DIFFERENTIATION INTO MIOCARDIAL CELLS INDUCTION | 2004 |
|
RU2392315C2 |
| LIVER ORGANOID, VERSIONS OF USE THEREOF AND CULTURE METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2579995C2 |
| METHOD OF INDUCTION OF PLURIPOTENT STEM CELLS DIFFERENTIATION INTO CARDIOMYOCYTES | 2007 |
|
RU2433174C2 |
| DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS | 2008 |
|
RU2465323C2 |
| CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS, CONTAINING THEREOF | 2010 |
|
RU2555545C2 |
| IMPROVED DIFFERENTIATION METHOD | 2017 |
|
RU2772435C2 |
| CULTURE MEDIUM FOR STEM CELLS | 2012 |
|
RU2714256C2 |
